在儿科慢性病中针对肠道微生物群的治疗方法:差距和机会
Arpana Iyengar1, Balamurugan Ramadass2, Shruthi Venkatesh3
1Department of Pediatric Nephrology, St. John's National Academy of Health Sciences, Bangalore, India, 560034. arpanaiyengar@gmail.com.
Pediatric nephrology (Berlin, Germany)
|April 30, 2025
概括
准肠道微生物群可能有助于患有慢性病 (CKD) 的儿童. 这篇评论探讨了饮食,益生菌和便移植等疗法,以改善肠道健康并减少CKD并发症.
科学领域:
- 儿科脏病学 儿科脏病学
- 胃肠病学 胃肠病学
- 微生物组研究 微生物组研究
背景情况:
- 肠道微生物组在慢性病 (CKD) 中起着复杂的作用.
- 了解微生物群-肠轴对于儿科CKD管理至关重要.
- 对于专门针对患有CKD的儿童的肠道向疗法的研究有限.
研究的目的:
- 为儿童慢性脏病提供肠道向治疗策略的概述.
- 探索微生物群调制在改善儿童慢性病的临床结果的潜力.
主要方法:
- 对CKD中肠道向治疗的现有文献的审查.
- 包括营养干预措施 (纤维,植物化学品,发酵食品,TCM).
- 考虑益生菌,共生菌,口服吸收剂和便微生物移植.
主要成果:
- 针对肠道微生物群的疗法可以在尿性环境中重新平衡肠道微生物群.
- 潜在的好处包括改善肠道屏障功能和减少尿素毒素.
- 疗法可以增强短链脂肪酸 (SCFA) 生产并减少炎症.
结论:
- 针对肠道微生物群的治疗方法对儿科慢性病有前途.
- 需要进一步的研究来评估儿童的临床疗效.
- 恢复肠道微生物群平衡是关键的治疗目标.
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
79
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
79
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
96
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
96
Drug Elimination by Renal Route: Tubular Secretion
2.1K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.1K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
100
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
100
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
272
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
272


